Cargando…
Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens
Antiretroviral therapies (ART) are strongly associated with weight gain and metabolic syndrome (MetS) development in HIV-infected patients. Few studies have evaluated the association between gut microbiota and integrase strand transfer inhibitor (INSTI)-based and protease inhibitor (PI)-based regime...
Autores principales: | Baltazar-Díaz, Tonatiuh Abimael, Amador-Lara, Fernando, Andrade-Villanueva, Jaime F., González-Hernández, Luz Alicia, Cabrera-Silva, Rodolfo Ismael, Sánchez-Reyes, Karina, Álvarez-Zavala, Monserrat, Valenzuela-Ramírez, Aldo, Del Toro-Arreola, Susana, Bueno-Topete, Miriam Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146710/ https://www.ncbi.nlm.nih.gov/pubmed/37110374 http://dx.doi.org/10.3390/microorganisms11040951 |
Ejemplares similares
-
334. Weight Change Associated with Antiretroviral Therapy Switch to Integrase Strand Transfer Inhibitor-Based Regimens
por: Saber, Saghar, et al.
Publicado: (2019) -
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort
por: Focà, Emanuele, et al.
Publicado: (2021) -
Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance
por: Demarest, James, et al.
Publicado: (2018) -
Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013) -
Initiation of antiretroviral therapy with integrase strand-transfer inhibitor-based regimens and reduction of the risk of horizontal transmission of HIV-1
por: Berenguer, Juan, et al.
Publicado: (2019)